USA v. Indivior Inc. et al
-
January 04, 2021
DOJ Attys Dish On Indivior Opioid Case As Sentencing Wraps
In an interview with Law360, the U.S. Department of Justice attorneys who prosecuted Indivior and two executives for illicit opioid marketing spotlighted the unusually strict compliance rules now hanging over the company and pointedly contrasted Indivior's no-holds-barred legal defense with the cooperative approaches of drugmakers in other cases.
-
October 21, 2020
Where DOJ's Opioid Blitz Stands After Purdue's Criminal Case
The U.S. Department of Justice's multibillion-dollar felony case blaming Purdue Pharma for "a national tragedy of addiction and deaths" involving narcotic painkillers is just one part of the DOJ's fast-growing criminal crackdown on the drug industry's opioid-crisis profiteering.
-
July 24, 2020
Indivior To Pay $600M To Settle Suboxone Charges
Indivior PLC said Friday it has agreed to pay $600 million to settle charges related to its opioid treatment Suboxone, ending litigation and investigations into claims about the safety of the drug's film form that enforcers say constituted fraud and unfair competition.
-
March 31, 2020
Indivior Again Fails To Dodge Feds' Opioid Marketing Case
A Virginia federal judge on Tuesday refused to dismantle a criminal case accusing Indivior of fraudulently marketing opioid addiction drug Suboxone Film, finding the federal government's wire fraud allegations were up to snuff.
-
November 15, 2019
Indivior Can't Duck Opioid Marketing Fraud Indictment
Indivior can't shed an indictment alleging it engaged in fraudulent opioid marketing just because prosecutors gave a grand jury evidence about a doctor's unrelated fraud convictions, a Virginia federal judge has ruled, saying the company's concerns about guilt by association were overstated.
-
September 13, 2019
Jones Day Attys 'Very Much Regret' Grand Jury Redaction Slip
Jones Day on Friday expressed remorse for exposing details about grand jury proceedings in a criminal case alleging fraudulent opioid marketing, telling a Virginia federal judge that a software oversight allowed a reporter to peek behind faulty redactions in a court filing.
-
September 11, 2019
Jones Day Faces Sanctions Threat After Redaction Flub
A Virginia federal judge on Wednesday raised the specter of sanctions for Jones Day after the firm accidentally publicized details about grand jury proceedings in a criminal opioid case with multibillion-dollar stakes.
-
September 10, 2019
Jones Day Botches Grand Jury Redaction In Attack On DOJ
Jones Day inadvertently disclosed details about grand jury proceedings by failing to properly redact a court filing this week that accused the U.S. Department of Justice of serious misconduct in a criminal opioid case against Indivior PLC.
-
August 14, 2019
DOJ Takes Another Shot At Suboxone Film Fraud Case
Federal prosecutors on Wednesday took another swing at Indivior Inc., the maker of opioid-dependence treatment Suboxone Film, with a new indictment accusing the company of misrepresenting to federal regulators the risk to children posed by the drug.
-
July 22, 2019
DOJ Errors Doom Suboxone Film Fraud Case, Indivior Says
Indivior has urged a federal judge to toss an indictment accusing it of misrepresenting the risk of abuse posed to children by its opioid-dependence treatment Suboxone Film, claiming federal prosecutors included inadmissible references to a doctor's health care fraud convictions and possibly even intentionally misled the grand jury.